All PlansCoverageMedium impact
Endovascular Therapies for Extracranial Vertebral Artery Disease
Blue Cross & Blue Shield of Mississippi·MS · Neurology, Radiology, Cardiology +2 more·Medical Policy
We identified it
Jun 20, 2026
Summary
This is an established policy (not a change) that classifies endovascular therapies for extracranial vertebral artery disease as investigational/not covered. The policy has remained unchanged since 2015 and continues to deny coverage for percutaneous transluminal angioplasty with or without stenting for vertebral artery diseases.
Action Required
Immediately: Billing team should verify that claims for endovascular procedures targeting extracranial vertebral artery disease (segments V1-V3) are not being submitted, as these are considered investigational and will be denied. Ensure providers are aware that only intracranial procedures may have limited coverage under FDA humanitarian device exemption.